Cleveland Scott York is launching a new webinar programme with a talk on strategically guided research, delivered by Dr John Normanton of IPgeniX, and Dr Adrian Bradley of Cleveland Scott York.

Thursday 22 February 2024 – 12:00 GMT, 13:00 CET


CONTENT: Investors prefer startups with patents. A well-structured patent portfolio offers a significant competitive advantage, and provides concrete evidence of innovation. The filing of patent applications in the seed or early growth stage is associated with a higher likelihood of subsequent VC funding, with a 6.4 times higher likelihood of funding for startups that filed for patents.

It is therefore important that research conducted within startups is optimised to generate intellectual property. The talk will focus on strategies to analyse your existing IP and plan future research to disclose areas that may have been overlooked using a more traditional approach. The session will include case studies of how this approach has been used successfully in the fields of biotechnology and pharmaceuticals.

Patent portfolio managers; in-house counsel with responsibility for patent budget; technology transfer managers at universities and research institutes; patent strategists.


Dr John Normanton
IPgeniX Limited

IPgeniX Limited, as the name is designed to imply, was specifically formed to service a need for expert multidisciplinary assistance to clients in suggesting, planning and guiding short-duration, low-cost R&D experiments designed to maximise the commercial value of patent portfolios to generate greater competitive advantage and maximise revenue from inventions.


Dr Adrian Bradley
Cleveland Scott York

Adrian is a Chartered and European Patent Attorney with particular expertise in the pharmaceutical and biotechnology sectors. He works extensively with universities and spin-outs around the world, and has built robust patent portfolios around a number of early-phase technologies.